Hutch News

Hutch News

Stories tagged 'cancer immunotherapy'

Nanoparticles open doors to cancer-fighting CAR T cells

Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy

July 2, 2018 | By Sabrina Richards / Fred Hutch News Service

Scientists at Fred Hutchinson Cancer Research Center have developed a cheap way to make cancers temporarily vulnerable to immune attack using liposome-based nanoparticles to carry immune-boosting drugs deep into tumors.

View story >


How does leukemia escape from immunotherapy?

New tech enables deep dive into mysterious results, sets stage for future improvements

April 16, 2018 | By Susan Keown / Fred Hutch News Service

“We don’t stop asking what we can do better”: Fred Hutch researchers delve into failures to learn how to improve an experimental cancer immunotherapy.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 14, 2016

Good News: Drs. Harmit Malik, Jesse Bloom win ASM awards; Fred Hutch team launches personalized anticancer vaccine project

View story >


New clues to treating deadly skin cancer

Small clinical trial finds two forms of immunotherapy may be better than one for treating metastatic melanoma

June 6, 2016 | By Rachel Tompa / Fred Hutch News Service

Matthew Flood, a retired EMT from the Tacoma Fire Department, is one of 10 patients with metastatic melanoma treated with an experimental combination of immunotherapies between 2011 and 2013. In a study published today in the Journal of Clinical Oncology, the research team described the small clinical trial and how the patients have fared in the years following their treatment. Flood is now in complete remission five years after receiving the combo immunotherapy.

View story >


Got ideas for better, faster cancer cures?

After Vice President Joe Biden’s Fred Hutch visit, we ask panelists for their ‘moonshot’ wish lists

April 15, 2016 | By Mary Engel / Fred Hutch News Service

As the National Cancer Moonshot Initiative moves forward, we asked some of the Seattle panelists who met with Vice President Joe Biden in March for their moonshot wish lists.

View story >


10 years to cancer cures 'actually plausible,' Fred Hutch president says

'We are on the threshold of amazing advances,' Dr. D. Gary Gilliland tells industry, research leaders

June 30, 2015 | By Andrea Detter / Fred Hutch News Service

The future of cancer therapy looks “incredibly promising,” Dr. D. Gary Gilliland, president and director of Fred Hutchinson Cancer Research Center, said Tuesday.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.